Epidemiology of autoimmune liver disease

Journal of Gastroenterology and Hepatology (Australia)

Volumn 18, Issue 10, 2003, Pages 1118-1128

  Feld, J J ^a   Heathcote, E J ^a  

^a TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

Autoimmune hepatitis; Chronic liver diseases; Primary biliary cirrhosis; Primary sclerosing cholangitis

Indexed keywords

ADULT; AGED; AUTOIMMUNE DISEASE; AUTOIMMUNE HEPATITIS; CHILD; CHRONIC LIVER DISEASE; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; FAMILIAL DISEASE; FEMALE; GENETIC PREDISPOSITION; HUMAN; INCIDENCE; LIVER DISEASE; MALE; PATHOGENESIS; PREVALENCE; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

EID: 0242571779     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2003.03165.x     Document Type: Review

References (148)

1. Kaplan MM. Primary biliary cirrhosis. N. Engl. J. Med. 1996; 335: 1570-80.
2. Krawitt EL. Medical Progress: Autoimmune hepatitis. N. Engl. J. Med. 1996; 334: 897-903.
3. Lee Y, Kaplan M. Primary sclerosing cholangitis. N. Engl. J. Med. 1995; 332: 924-33.
4. Czaja A. Frequency and nature of the variant forms of autoimmune liver disease. Hepatology 1998; 28: 360-5.
5. Triger DR. Primary biliary cirrhosis: An epidemiological study. BMJ 1980; 281: 772-5.
6. Eriksson S, Lindgren S. The prevalence and clinical spectrum of PBC in a defined population. Scand. J. Gastroenterol. 1984; 19: 971-6.
7. Triger DR, Berg PA, Rodes J. Epidemiology of primary biliary cirrhosis. Liver 1984; 4: 195-200.
8. Lofgren J, Jarnerot G, Danielsson D, Hemdal I. Incidence and prevalence of primary biliary cirrhosis in a defined population in Sweden. Scand. J. Gastroenterol. 1985; 20: 647-50.
9. Myszor M, James OFW. The epidemiology of primary biliary cirrhosis in Northeast England: An increasingly common disease? Q. J. Med. 1990; 75: 377-85.
10. Witt-Sullivan H, Heathcote J, Cauch K et al. The demography of primary biliary cirrhosis in Ontario. Can. Hepatol. 1990; 12: 98-105.
11. Danielsson A, Boquist L, Uddenfeldt P. Epidemiology of primary biliary cirrhosis in a defined rural population in the northern part of Sweden. Hepatology 1990; 11: 458-64.
12. Watson RGP, Angus PW, Dewar M, Goss B, Sewell RB, Smallwood RA. Low prevalence of primary biliary cirrhosis (PBC) in Victoria, Australia. Gut 1995; 36: 927-30.
13. Remmel T, Remmel H, Uibo R, Salupere V. Primary biliary cirrhosis in Estonia with special reference to incidence, prevalence and clinical features and outcome. Scand. J. Gastroenterol. 1995; 30: 367-71.
14. Inoue K, Hirohara J, Nakano T et al. Prediction of prognosis of primary biliary cirrhosis in Japan. Liver 1995; 15: 70-7.
15. Metcalf JV, Bhopal RS, Gray J, Howel D, James OFW. Incidence and prevalence of primary biliary cirrhosis in the city of Newcastle-Upon-Tyne, England. Int. J. Epidemiol. 1997; 26: 830-6.
16. Boberg KM, Aadland E, Jahnsen J, Raknerud N, Stiris M, Bell H. Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis and autoimmune hepatitis in a Norwegian population. Scand. J. Gastroenterol. 1998; 33: 99-103.
17. Prince MI, Chetwynd A, Diggle P, Jarner M, Melcalf JV, James OF. The geographical distribution of primary biliary cirrhosis in a well defined cohort. Hepatology 2001; 34: 1083-8.
18. Kim WR, Lindor KD, Locke GR et al. Epidemiology and natural history of primary biliary cirrhosis in a US community. Gastroentemlogy 2000; 119: 1631-6.
19. James OFW, Bhopal R, Howl D, Gray J, Burt AD, Metcalf JV. Primary biliary cirrhosis once rare, now common in the United Kingdom? Hepatology 1999; 30: 390-4.
20. Puri AS, Kumar N, Gondal R, Lamba GS, Jain M. Primary biliary cirrhosis: an Indian experience. Indian J. Gastroenterol. 2001; 20: 28-9.
21. Metcalf JV, James OFW. The geoepidemiology of primary biliary cirrhosis. Semin. Liver Dis. 1997; 17: 13-22.
22. Mackay IR, Gershwin Me. Pathogenesis of primary biliary cirrhosis. In: Krawitt EL, Wiesner RH, Nishioka M, eds. Autoimmune Liver Diseases, 2nd edn. Amsterdam: Elsevier, 1998; 49-69.
23. Jones DEJ, Watt FE, Metcalf JV, Bassendine MF, James OFW. Familial primary biliary cirrhosis reassessed: a geographically-based population study. J. Hepatol. 1999; 30: 402-7.
24. Metcalf JV, Mitchison HC, Palmer JM, Jones DE, Bassendine MF, James OF. Natural history of early primary biliary cirrhosis. Lancet 1996; 348: 1399-402.
25. Kisand KE, Metskula K, Kisand KV, Kivik T, Gershwin ME, Uibo R. The follow-up of asymptomatic persons with antibodies to pyruvate dehydrogenase in adult population samples. J. Gastroenterol. 2001; 36: 248-54.
26. Mattalia A, Ouaranta S, Leung PS et al. Characterization of antimitochondrial antibodies in healthy adults. Hepatology 1998; 27: 656-61.
27. Turchany JM, Uibo R, Kivik T et al. A study of antimitochondrial antibodies in a random population in Estonia. Am. J. Gastroenterol. 1997; 92: 124-6.
28. Czaja AJ, Carpenter HA. Validation of a scoring system for the diagnosis of autoimmune hepatitis. Dig. Dis. Sci. 1996; 41: 305-14.
29. International Autoimmune Hepatitis Group Report. A review of criteria for a diagnosis of autoimmune hepatitis. J. Hepatol. 1999; 31: 929-38.
30. Bjarnarson I, Magnusson B, Bjornsson S. Idiopathic chronic active hepatitis in Iceland. Acta Med. Scand. 1982; 211: 305-7.
31. Olsson R, Lindberg J, Weiland O, Nilsson L. Members of the Swedish Internal medicine Liver Club and Clinics for Infectious Diseases. Chronic active hepatitis in Sweden. The etiologic spectrum, clinical presentation and laboratory profile. Scand. J. Gastroenterol. 1988; 23: 463-70.
32. Tanner AR, Dellipiani AW. Chronic active hepatitis: a sixteen year survey at a district general hospital. Postgrad. Med. J. 1989; 65: 725-8.
33. Homberg JC, Abuaf N, Bernard O et al. Chronic active hepatitis associated with anti-liver-kidney microsome antibody type 1: a second type of 'autoimmune' hepatitis. Hepatology 1987; 7: 1333-9.
34. Lindgren S, Braun HB, Nemeth A et al. Absence of LKM1 antibody reactivity in autoimmune and hepatitis-C related chronic liver disease in Sweden. Scand. J. Gastroenterol. 1997; 32: 175-8.
35. Escorsell A, Pares A, Rodes J, Solis-Herruzo JA, Miras M, Morena De la E. Epidemiology of primary sclerosing cholangitis in Spain. J. Hepatol. 1994; 21: 787-91.
36. Olsson R, Danielsson A, Jarnerot G et al. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis. Gastroenterology 1991; 100: 1319-23.
37. Dahlan YM, Smith L, Simmonds D, Heathcote EJ, Bain V. Pediatric onset of primary biliary cirrhosis [Abstract]. Hepatol. 2001; 34: 625A.
38. Sherlock S, Scheuer PJ. The presentation and diagnosis of 100 patients with primary biliary cirrhosis. N. Engl. J. Med. 1973; 289: 674-8.
39. Jeffrey G, Reed WD, Shilkin KB. Primary biliary cirrhosis: clinicopathologicical characteristics and outcome. J. Gastroenterol. Hepatol. 1990; 5: 639-45.
40. Lucey MR, Neuberger JM, Williams R. Primary biliary cirrhosis in men. Gut 1986; 27: 1373-6.
41. Donaldson PT, Doherty DG, Hayllar KM, McFarlane IG, Johnson PJ, Williams R. Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors. Hepatology 1991; 13: 701-6.
42. Duchini A, McHutchison JG, Pockros PJ. LKM-Positive autoimmune hepatitis in the western United States: a Case Series. Am. J. Gastroenterol. 2000; 95: 3238-41.
43. Floreani A, Zancan L, Melis A, Baragiotta A, Chiaramonte M. Primary sclerosing cholangitis (PSC): clinical, laboratory and survival analysis in children and adults. Liver 1999; 19: 228-33.
44. Wiesner RH, Grambasch PM, Dickson ER et al. Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis. Hepatology 1989; 10: 430-6.
45. Debray D, Pariente D, Urvoas E, Hadchouel M, Bernard O. Sclerosing cholangitis in children. J. Pediatr. 1994; 124: 49-56.
46. Wilshanski M, Chait P, Wade JA et al. Primary sclerosing cholangitis in 32 children: clinical, laboratory and radiographic features with survival analyses. Hepatology 1995; 22: 1415-22.
47. Lim KN, Casanova RL, Boyer TD, Bruno CJ. Autoimmune hepatitis in African Americans: presenting features and response to therapy. Am. J. Gastroenterol. 2001; 96: 3390-4.
48. Gregorio GV, Portmann B, Karani J et al. Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study. Hepatology 2001; 33: 544-53.
49. Toda G, Zeniya M, Watanabe F et al. Present status of autoimmune hepatitis in Japan - correlating the characteristics with international criteria in an area with a high rate of HCV infection. Japanese National Study Group of Autoimmune Hepatitis. J. Hepatol. 1997; 26: 1207-12.
50. Gupta R, Agarwal SR, Jain M, Malhotra V, Sarin SK. Autoimmune hepatitis in the Indian subcontinent: 7 years experience. J. Gastroenterol. Hepatol. 2001; 16: 1144-8.
51. Lee, Ym, Teo Ek NG, Tm Khor C, Fock KM. Autoimmune hepatitis in Singapore: a rare syndrome affecting middle-aged women. J. Gastroenterol. Hepatol. 2001; 16: 1384-9.
52. Bach N, Schaffner F. Familial primary biliary cirrhosis. J. Hepatol. 1994; 20: 698-701.
53. Tanaka A, Borchers AT, Ishibashi H, Ansari AA, Keen CL, Gershwin E. Genetic and familial considerations of primary biliary cirrhosis. Am. J. Gastroenterol. 2001; 96: 8-15.
54. Brind AM, Bray GP, Portmann BC, Williams R. Prevalence and pattern of familial disease in primary biliary cirrhosis. Gut 1995; 36: 615-17.
55. Tsuji K, Watanabe Y, Van de Water J et al. Familial primary biliary cirrhosis in Hiroshima. J. Autoimmun. 1999; 13: 171-8.
56. Floreani A, Naccarato R, Chiaramonte M. Prevalence of familial disease in primary biliary cirrhosis in Italy. J. Hepatol. 1997; 26: 737-8.
57. Kaplan MM, Rabson AR, Lee YM et al. Discordant occurrence of primary biliary cirrhosis in monozygotic twins. N. Engl. J. Med. 1994; 331: 952.
58. Friedrich C. More on primary biliary cirrhosis in monozygotic twins. N. Engl. J. Med. 1995; 332: 336-8.
59. Lachaux A, Bouvier R, Cozzani E et al. Familial autoimmune enteropathy with circulating anti-bullous pemphigoid antibodies and chronic autoimmune hepatitis. J. Pediatr. 1994; 125: 858-62.
60. Ohira H, Shinzawa J, Suzuki T et al. Two sister cases of autoimmune hepatitis. Fukushima J. Med. Sci. 1998; 44: 113-20.
61. Constans J, Bernard P, Bioulac-Sage P, Barcat D, Conri C. [Familial autoimmune hepatitis and C4 deficiency.] Rev. Med. Interne 1998; 19: 731-3 (In French).
62. Findor JA, Sorda JA, Daruich JR, Manero EF. Familial association in autoimmune liver disease. Medicina (B. Aires) 2002; 62: 241-4.
63. Habior A, Rawa T, Oruulowska J et al. Association of primary sclerosing cholangitis, ulcerative colitis and coeliac disease in female siblings. Eur. J. Gastroenterol. 2002; 14: 787-91.
64. Quigley EM, Larusso NF, Ludwig JG, MacSween RN, Birnie GG, Watkinson G. Familial occurrence of primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1983; 85: 1160-5.
65. Ogura Y, Bonen DK, Inohara N et al. A frameshift mutation in NOD2 associated with the susceptibility to Crohn's disease. Nature 2001; 411: 603-6.
66. Hugot JP, Chamaillard M, Zouali H et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001; 411: 599-603.
67. Johnston DE, Kaplan MM, Miller KB, Connors CM, Milford EL. Histocompatibility antigens in primary biliary cirrhosis. Am. J. Gastroenterol. 1987; 82: 1127-9.
68. Manns MP, Bremm A, Schneider PM et al. HLA DRw8 and complement C4 deficiency as risk factors in primary biliary cirrhosis. Gastroenterology 1991; 101: 1367-73.
69. Morling N, Dalhoff K, Fugger L et al. DNA polymorphism of HLA class II genes in primary biliary cirrhosis. Immunogenetics 1992; 35: 112-16.
70. Gores GJ, Moore SB, Fisher LD, Powell FC, Dickson ER. Primary biliary cirrhosis: Associations with class II major histocompatibility complex antigens. Hepatology 1987; 7: 889-92.
71. Underhill J, Donaldson P, Bray G, Doherty D, Portmann B, Williams R. Susceptibility to primary biliary cirrhosis is associated with the HLA-DR8-DQB1*0402 haplotype. Hepatology 1992; 16: 1404-8.
72. Gregory WL, Mehal W, Dunn AN et al. Primary biliary cirrhosis: Contribution of HLA class II allele DR8. Q. J. Med. 1993; 86: 393-9.
73. Begovich AB, Klitz W, Moonsamy PV, Van de Water J, Paltz G, Gershwin ME. Genes within the HLA class II region confer both predisposition and resistance to primary biliary cirrhosis. Tissue Antigens 1994; 43: 71-7.
74. Ercilla G, Pares A, Arriaga F et al. Primary biliary cirrhosis associated with HLA-DRw3. Tissue Antigens 1979; 14: 449-52.
75. Manabe K, Donaldson PT, Underhill JA et al. Human leukocyte antigen A1-B8-DR3-DQ2-DPB1*0401 extended haplotype in autoimmune hepatitis. Hepatology 1993; 18: 1334-7.
76. Czaja AJ, Strettell MD, Thomson LJ et al. Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis. Hepatology 1997; 25: 317-23.
77. Donaldson PT, Farrant JM, Wilkinson ML, Hayllar K, Portmann BC, Williams R. Dual association of HLA DR2 and DR3 with primary sclerosing cholangitis. Hepatology 1991; 13: 129-33.
78. Mella JG, Roschmann E, Maier K-P, Volk BA. Association of primary biliary cirrhosis with the allele HLA-DPB1*0301 in a German population. Hepatology 1995; 21: 398-402.
79. Seki T, Kiyosawa K, Ota M et al. Association of primary biliary cirrhosis with human leukocyte antigen DPB1*0501 in Japanese patients. Hepatology 1993; 18: 73-8.
80. Seki T, Kiyosawa K, Inoko H, Ota M. Association of autoimmune hepatitis with human leukocyte antigen Bw54 and DR4 in Japanese patients. Hepatology 1990; 12: 1300-4.
81. Seki T, Ota M, Furuta S et al. HLA class II molecules and autoimmune hepatitis susceptibility in Japanese patients. Gastroenterology 1992; 103: 1041-7.
82. Mehal WZ, Lo YM, Wordsworth BP et al. HLA DR4 is a marker for rapid disease progression in primary sclerosing cholangitis. Gastroenterology 1994; 106: 160-7.
83. Fainboim L, Marcos Y, Pando M et al. Chronic active autoimmune hepatitis in children. Strong association with a particular HLA-DR6 (HLA-DRB1*1301) haplotype. Hum. Immunol. 1994; 41: 146-50.
84. Pando M, Larriba J, Fernandez GC et al. Pediatric and adult forms of type 1 autoimmune hepatitis in Argentina: Evidence for a differential genetic predisposition. Hepatology 1999; 30: 1374-80.
85. Prochazka EJ, Tersaki H, Park MS, Goldstein LI, Bussuttil RW. Association of primary sclerosing cholangitis with HLA DRw52a. N. Engl. J. Med. 1990; 17: 317-22.
86. Boberg KM, Spurkland A, Rocca G et al. The HLA-DR3,DQ2 heterozygous genotype is associated with an accelerated progression of primary sclerosing cholangitis. Scand. J. Gastroenterol. 2001; 36: 886-90.
87. Miyamori H, Kato Y, Kobayashi K, Hattori N. HLA antigens in Japanese patients with primary biliary cirrhosis and autoimmune hepatitis. Digestion 1983; 26: 213-17.
88. Bassendine MF, Dewar PJ, James OF. HLA-DR antigens in primary biliary cirrhosis: Lack of association. Gut 1985; 26: 625-8.
89. Briggs DC, Donaldson PT, Hayes P, Welsh KI, Williams R, Neuberger JM. A major histocompatibility complex class III allotype (C4B2) associated with primary biliary cirrhosis (PBC). Tissue Antigens 1987; 29: 141-5.
90. Onishi S, Sakamaki T, Maeda T et al. DNA typing of HLA class II genes; DRB1*0803 increases the susceptibility of Japanese to primary biliary cirrhosis. J. Hepatol. 1994; 21: 1053-60.
91. Seldin MF, Amos CI, Ward R, Gregersen PK. The genetics revolution and the assault on rheumatoid arthritis. Arthritis Rheum. 1999; 42: 1071-9.
92. Aitman TJ, Todd JA. Molecular genetics of diabetes mellitus. Bailleiere's Clin. Endocrinol. Metab. 1995; 9: 631-56.
93. Gordon MA, Oppenheim E, Camp NJ, di Giovine FS, Duff GW, Gleeson D. Primary biliary cirrhosis shows association with genetic polymorphism of tumour necrosis factor alpha promoter region. J. Hepatol. 1999; 31: 242-7.
94. Jones DE, Watt FE, Grove J et al. Tumour necrosis factor-alpha promoter polymorphism in primary biliary cirrhosis. J. Hepatol. 1999; 39: 232-6.
95. Gregory WL, Daly AK, Dunn AN et al. Analysis of HLA-class-II-encoded antigen-processing genes TAP1 and TAP2 in primary biliary cirrhosis. Q. J. Med. 1994; 87: 237-44.
96. Zappala F, Grove J, Watt FE et al. No evidence for involvement of the interleukin-10-592 promoter polymorphism in genetic susceptibility to primary biliary cirrhosis. J. Hepatol. 1998; 28: 820-3.
97. Graham AM, Dollinger MM, Howie SEM, Harrison DJ. Identification of novel alleles at the polymorphic microsatellite repeat region in the human NRAMP1 gene promoter: Analysis of allele frequencies in primary biliary cirrhosis. J. Med. Genet. 2000; 37: 150-2.
98. Springer JE, Cole DE, Rubin LA et al. Vitamin D-receptor genotypes as independent genetic predictors of decreased bone mineral density in primary biliary cirrhosis. Gastroenterology 2000; 118: 145-51.
99. Czaja Aj Kruger M, Santrach PJ, Moore SB, Manns MP. Genetic distinctions between types 1 and 2 autoimmune hepatitis. Am. J. Gastroenterol. 1998; 93: 1394-5.
100. Goldberg AC, Bittencourt PL, Mougin B et al. Analysis of HLA haplotypes in autoimmune hepatitis type identifying the major susceptibility locus. Hum. Immunol. 2001; 62: 165-9.
101. Zetterquist H, Broome U, Einarsson K, Olerup O. HLA class II genes in primary sclerosing cholangitis and chronic inflammatory bowel disease - no HLA DRw52a association in Swedish patients with sclerosing cholangitis. Gut 1992; 33: 942-6.
102. Farrant JM, Doherty DG, Donaldson PT et al. Amino acid substitution as position 38 of DR b polypeptide confers susceptibility to and protection from primary sclerosing cholangitis. Hepatology 1992; 16: 390-5.
103. Saarinen S, Olerup O, Broome U. Increased frequency of autoimmune diseases in patients with primary sclerosing cholangitis. Am. J. Gastroenterol. 2000; 95: 3195-9.
104. Olerup O, Olsson R, Hultcrantz R, Broome U. HLA-DR and HLA-DQ are not markers for rapid disease progression in primary sclerosing cholangitis. Gastroenterology 1995; 108: 870-8.
105. Uddenfeldt P, Danielsson A, Forssell A, Holm M, Ostberg Y. Features of Sjogren's syndrome in patients with primary biliary cirrhosis. J. Intern. Med. 1991; 230: 443-8.
106. Nagai Y, Ieki Y, Oshawa K, Kobayashi K. Simultaneously found transient hypothyroidism due to Hashimoto's thyroiditis, autoimmune hepatitis and isolated ACTH deficiency after cessation of glucocorticoid administration. Endocr. J. 1997; 44: 453-8.
107. Inoue K, Okajima T, Tanaka E et al. A case of Graves' disease associated with autoimmune hepatitis and mixed connective tissue disease. Endocr. J. 1999; 46: 173-7.
108. Rasmussen HH, Fallingborg JF, Mortensen PB, Vyberg M, Tage-Jensen U, Rasmussen SN. Hepatobiliary dysfunction and primary sclerosing cholangitis in patients with Crohn's disease. Scand. J. Gastroenterol. 1997; 32: 604-10.
109. Seibold F, Weber P, Jenss H, Scherulen M. Autoimmune hepatitis in inflammatory bowel disease: report of two unusual cases. Z. Gastroenterol. 1997; 35: 29-32.
110. Soua H, Pousse H, Ladeb F et al. [Histiocytosis X and sclerosing cholangitis]. Ann. Pediatr. (Paris) 1993; 40: 316-19 (in French).
111. Shoji I, Takagi T, Kasukawa R. Anti-centromere antibody and CREST syndrome in patients with primary biliary cirrhosis. Intern. Med. 1992; 31: 1348-55.
112. Kondo H, Kajii E, Oyamada T, Kasahara Y. Direct antiglobulin test negative autoimmune hemolytic anemia associated with autoimmune hepatitis. Int. J. Hematol. 1998; 68: 439-43.
113. Gow PJ, Felming KA, Chapman RW. Primary sclerosing cholangitis associated with rheumatoid arthritis and HLA DR4: is the association a marker of patients with progressive liver disease? J. Hepatol. 2001; 34: 631-5.
114. Matsumoto T, Kobayashi S, Shimizu H et al. The liver in collagen diseases. pathologic study of 160 cases with particular reference to hepatic arteritis, primary biliary cirrhosis, autoimmune hepatitis and nodular regenerative hyperplasia of the liver. Liver 2000; 20: 366-73.
115. Wada M, Kamimota H, Park SY, Shintani S, Nakasho K. Autoimmune hepatitis concomitant with hypergammaglobulinemic purpura, immune thrombocytopenia, and Sjogren's syndrome. Intern. Med. 2001; 40: 308-11.
116. Kornfeld D, Ekbom A, Ihre T. Is there an excess risk for colorectal cancer in patients with ulcerative colitis and concomitant primary sclerosing cholangitis? A population based study. Gut 1997; 41: 522-5.
117. Elta SH, Spersky RA, Goldberg MJ, Connors CM, Miller KB, Kaplan MM. Increased incidence of hypothyroidism in primary biliary cirrhosis. Dig. Dis. Sci. 1983; 28: 971-5.
118. Satoh T, Hirakata M, Yoshida T et al. Systemic lupus erythmatosus associated with autoimmune hepatitis two cases with novel autoantibodies to transfer RNA-related antigens. Clin. Rheumatol. 1997; 16: 305-9.
119. Dickey W, McMillan SA, Callender ME. High prevalence of celiac sprue among patients with primary biliary cirrhosis. J. Clin. Gastroenterol. 1997; 25: 328-9.
120. Venturini I, Cosenz R, Miglioli L et al. Adult celiac disease and primary sclerosing cholangitis: two case reports. Hepatogastroenterology 1998; 45: 2344-7.
121. Laitt RD, Hubscher SG, Buckels JA, Darby S, Elias E. Sclerosing cholangitis associated with multifocal fibrosis: a case report. Gut 1992; 33: 1430-2.
122. Toblli JE, Findor J, Sorda J, Bruch Igartua E, Hasenclever K, Collado HD. Latent distal renal tubular acidosis (dRTA) in primary biliary cirrhosis (PBC) and chronic autoimmune hepatitis (CAH). Acta Gastroenterol. Latinoam. 1993; 23: 235-8.
123. Volta U, De Franceschi L, Molinaro N et al. Frequency and significance of anti-gliadin and anti-endomysial antibodies in autoimmune hepatitis. Dig. Dis. Sci. 1998; 43: 2190-5.
124. Han YS, Kim BH, Kim TH et al. Autoimmune hepatitis in a patient with myasthenia gravis and thymoma - a report on the first case in Korea. Korean J. Intern. Med. 2000; 15: 151-5.
125. Ludwig J, LaRusso NF, Wiesner RH. The syndrome of primary sclerosing cholangitis. Prog. Liver Dis. 1990; 9: 555-66.
126. Kochhar R, Coenka MK, Das K et al. Primary sclerosing cholangitis: an experience from India. J. Gastroenterol. Hepatol. 1996; 11: 429-33.
127. BahraktarY, Arslan S, Saglam F, Uzunalimoglu B, Kayhan B. What is the association of primary sclerosing cholangitis with sex and inflammatory bowel disease in Turkish patients? Hepatogastroenterology 1998; 45: 2064-72.
128. Okada H, Mizuno M, Yamamoto K, Tsuji T. Primary sclerosing cholangitis in Japanese patients: association with inflammatory bowel disease. Acta Med. Okayama 1996; 50: 227-35.
129. Logan RFA, Edmond M, Sommerville KW, Langman MJS. Smoking and ulcerative colitis. BMJ 1984; 288: 751-3.
130. Lindberg E, Tysk C, Andersson K, Jarnerot G. Smoking and inflammatory bowel disease. A case control study. Gut 1988; 29: 352-7.
131. Benoni C, Nilsson A. Smoking habits in patients with inflammatory bowl disease. Scand. J. Gastroenterol. 1984; 19: 824-30.
132. Logan R. Appendectomy and ulcerative colitis: what connection? Gastroenterology 1994; 106: 1382-4.
133. Rutgeerts P, D'Haens G, Hiele M, Geboes K, Vantrappen G. Appendectomy protects against ulcerative colitis. Gastroenterology 1994; 106: 1251-3.
134. Van Erpecum KJ, Sander JH, Smits M et al. Risk of primary sclerosing cholangitis is associated with nonsmoking behavior. Gastroenterology 1996; 110: 1503-6.
135. Mills PR, Boyle P, Quigley EM et al. Primary biliary cirrhosis: an increased incidence of extrahepatic malignancies? J. Clin. Path. 1982; 35: 541-3.
136. Goudie BM, Burt AD, Boyle P et al. Breast cancer in women with primary biliary cirrhosis. BMJ 1985; 291: 1597-8.
137. Wolke AM, Schaffner F, Kapelman B, Sacks HS. Malignancy in primary biliary cirrhosis: high incidence of breast cancer in affected women. Am. J. Med. 1984; 76: 1075-8.
138. Floreani A, Biagini M, Chiaramonte M, Milani S, Surrenti C, Naccarato R. Incidence of hepatic and extra-hepatic malignancies in primary biliary cirrhosis (PBC). Ital. J. Gastroenterol. 1993; 25: 473-6.
139. Van Dam GM, Gips CH. Primary biliary cirrhosis in the Netherlands. Scand. J. Gastroenterol. 1997; 32: 77-83.
140. Loof L, Adami HO, Sparen P et al. Cancer risk in primary biliary cirrhosis: a population-based study from Sweden. Hepatology 1994; 20: 101-4.
141. Sorenson H, Frijs S, Thulstrup AM et al. Risk of liver and other types of cancer in patients with cirrhosis: a nationwide cohort study in Denmark. Hepatology 1998; 28: 921-5.
142. Howel D, Metcalf JV, Gray J, Newman WL, Jones DEJ, James OFW. Cancer risk in primary biliary cirrhosis: a study in northern England. Gut 1999; 45: 756-60.
143. Turissini SB, Kaplan MM. Hepatocellular carcinoma in primary biliary cirrhosis. Am. J. Gastroenterol. 1997; 92: 626-8.
144. Caballeria L, Pares A, Castells A, Gines A, Bru C, Rodes J. Hepatocellular carcinoma in primary biliary cirrhosis: similar incidence to that in hepatitis C virus-related cirrhosis. Am. J. Gastroenterol. 2001; 96: 1160-3.
145. Melia WM, Johnson PJ, Neuberger J, Zaman S, Portmann BC, Williams R. Hepatocellular carcinoma in primary biliary cirrhosis: detection by alpha-fetoprotein estimation. Gastroenterology 1984; 87: 663-6.
146. McNair ANB, Maloney M, Portmann BV, Williams R, McFarlane IG. Autoimmune hepatitis overlapping with primary sclerosing cholangitis in five cases. Am. J. Gastroenterol. 1998; 93: 777-84.
147. el-Shabrawi M, Wilkinson ML, Portmann B et al. Primary sclerosing cholangitis in childhood. Gastroenterology 1987; 92: 1226-35.
148. Czaja AJ, Santrach PJ, Moore S. Shared genetic risk factors in autoimmune liver disease. Dig. Dis. Sci. 2001; 46: 140-7.